FDA Approves ARROW UltraQuik Needles

The ARROW UltraQuik peripheral nerve block needles by Teleflex International received 510(k) clearance from the FDA, according to Daily Finance.

Advertisement

The needles feature five grooved rings at the tip for better clinician identification with an ultrasound during single-inject peripheral nerve blocks.

More Articles on Anesthesia:
Somnia Anesthesia Releases New Case Studies on Anesthesia Leadership
ASA Presses for Anesthesiologist Meaningful Use Stage 3 Exemption
Noridian Adjusts Anesthesia Coverage Policy After Unintended Denials

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Artificial Intelligence

Advertisement

Comments are closed.